We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$40.9B
AUM Growth
+$7.77B
Cap. Flow
+$6.04B
Cap. Flow %
14.76%
Top 10 Hldgs %
24.44%
Holding
4,406
New
160
Increased
1,683
Reduced
2,046
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 11.19%
2 Financials 10.61%
3 Healthcare 9.53%
4 Communication Services 9.5%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
4151
Axsome Therapeutics
AXSM
$11.4B
$17 ﹤0.01%
3
UFAB
4152
DELISTED
Unique Fabricating, Inc.
UFAB
$17 ﹤0.01%
2
JMBA
4153
DELISTED
Jamba, Inc.
JMBA
$17 ﹤0.01%
2
APVO icon
4154
Aptevo Therapeutics
APVO
$5.01M
0
LPCN icon
4155
Lipocine
LPCN
$17.3M
0
NVIV
4156
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
0
CRDF icon
4157
Cardiff Oncology
CRDF
$80.1M
0
AMPE
4158
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
0
PFNX
4159
DELISTED
Pfenex Inc.
PFNX
$15 ﹤0.01%
5
NMRX
4160
DELISTED
Numerex Corp
NMRX
$15 ﹤0.01%
4
AMSC icon
4161
American Superconductor
AMSC
$1.5B
$14 ﹤0.01%
3
FCEL icon
4162
FuelCell Energy
FCEL
$1.59B
0
CRMD icon
4163
CorMedix
CRMD
$591M
$12 ﹤0.01%
5
ARCO icon
4164
Arcos Dorados Holdings
ARCO
$1.7B
$10 ﹤0.01%
1
CSTM icon
4165
Constellium
CSTM
$3.98B
$10 ﹤0.01%
1
IRMD icon
4166
iRadimed
IRMD
$1.15B
$10 ﹤0.01%
1
CEL
4167
DELISTED
Cellcom Israel, Ltd.
CEL
$9 ﹤0.01%
1
ANTH
4168
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$9 ﹤0.01%
6
HBIO icon
4169
Harvard Bioscience
HBIO
$28.8M
0
TTOO
4170
DELISTED
T2 Biosystems, Inc
TTOO
0
KONA
4171
DELISTED
Kona Grill, Inc.
KONA
$8 ﹤0.01%
2
MITL
4172
DELISTED
Mitel Networks Corporation
MITL
$8 ﹤0.01%
1
OCIP
4173
DELISTED
OCI Partners LP
OCIP
$8 ﹤0.01%
1
OIBR.C
4174
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$8 ﹤0.01%
1
PAYX icon
4175
PUT
Paychex
PAYX
$43.1B
$7 ﹤0.01%
1

Similar funds

BNP Paribas Financial Markets's Q3 2017 Portfolio in Review

As of Q3 2017, BNP Paribas Financial Markets held 4,406 positions worth $40.9B, up 23% from $33.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

BNP Paribas Financial Markets deployed $6.04B of net new capital in Q3 2017, opening 160 new positions and adding to 1,683 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 250,000 shares worth $44.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $197M trimmed.

  • BNP Paribas Financial Markets's largest Q3 2017 buy was iShares Russell 2000 Growth ETF: 250,000 shares worth $44.7M.
  • BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $1.03B increase.
  • BNP Paribas Financial Markets's biggest Q3 2017 reduction was Berkshire Hathaway Class B, cutting an estimated $197M.
  • BNP Paribas Financial Markets fully exited Reynolds American Inc in Q3 2017, selling an estimated $96.1M.
  • BNP Paribas Financial Markets's ten largest holdings make up 24% of its $40.9B portfolio in Q3 2017.
  • BNP Paribas Financial Markets opened 160 new positions and closed 164 in Q3 2017.
  • BNP Paribas Financial Markets's portfolio value rose 23% quarter-over-quarter to $40.9B.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2017, filed 3 Nov 2017.